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INTRODUCTION
Abdominal pa in , d iar rhea , hematochezia are the 
common symptoms seen in clinical gastroenterology. 
The underlying causes may not always be clear. Henoch-
Schönlein purpura (HSP) is one of  the uncommon 
causes and can be a challenging clinical problem[1]. 
Among the presenting symptoms, gastrointestinal (GI) 
complains occur in 50% to 85% of  patients[2]. Some HSP 
patients may develop serious GI complications, such as 
intussusception, obstruction and perforation, which may 
require surgical intervention on rare occasions[3-5]. Early 
diagnosis of  HSP presenting mainly with acute abdominal 
symptoms in adul ts remains a cha l lenge to both 
gastroenterologists and general surgeons, particularly if  
the abdominal symptoms precede the typical skin rash. 
Although HSP is more common in children, it has also 
been documented in adults[6]. In comparison to children, 
adult patients have more atypical symptoms and a poorer 
prognosis and need more intensive care[7]. Although lots 
of  efforts have been made, the mortality in adults with 
HSP is still higher than that in children. Doctors are 
eager to find a more effective therapy for the disease. 
Since antineutrophil cytoplasmic antibody (ANCA) 
was reported in 1982 by Bavis, many studies have shown 
that ANCA is a useful tool for the diagnosis of  systemic 
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Abstract
AIM: To test the clinical significance of antineutrophil 
cytoplasmic antibody (ANCA) in evaluation of adult 
Henoch-Schönlein purpura (HSP) patients presenting 
mainly with abdominal symptoms.
METHODS: Twenty-eight consecutive HSP patients who 
presented predominantly with abdominal symptoms were 
enrolled in this study. Control subjects included 27 age- 
and sex-matched patients with peptic ulcer disease, colon 
cancer, acute gastroenteritis, irritable bowel syndrome 
and colonic polyps. ANCA was measured by indirect 
immunofluorescence (IIF) in all patients, and follow-up 
ELISA was performed in patients with positive IIF tests.
RESULTS: ANCA was detected in 9 HSP patients by 
IIF (2 were positive for c-ANCA and 7 were positive for 
p-ANCA). No ANCA was found in the control group. The 
sensitivity and specificity of a positive ANCA test (either 
c- or p-ANCA) were 32.1% and 100% respectively. 
Only one out of the 9 patients with positive ANCA by 
IIF had positive ANCA by ELISA and the antigen was 
myeloperoxidase (MPO). The patients positive for ANCA 
had higher HSP clinical scores, and were more likely 
to have renal function impairment. Patients with late 
purpura development were also associated with more 
severe clinical manifestations.
CONCLUSION: A positive ANCA test is associated with 
more severe symptoms in HSP. After inflammatory bowel 
disease is excluded, a positive ANCA test provides a clue 
to the diagnosis of HSP presenting predominantly with 
abdominal symptoms.
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vasculitis, especially for the diagnosis and follow-up of  
microscopic polyangiitis and Wegener’s granulomatosis[8,9]. 
It was reported that ANCA is also detectable in patients 
with HSP. However, the prevalence of  HSP remains 
controversial, ranging 0%-79%[10-13]. It has been shown that 
the positive ANCA rate is as high as 82.3%[14], suggesting 
that ANCA can be used to confirm the diagnosis of  
HSP in children. In addition, some reports indicate that 
ANCA is also related to the severity of  autoimmunological 
diseases, such as Wegener’s granulomatosis[15], systemic 
vasculitis[16,17]. However, the relationship between ANCA 
and the severity of  HSP has not been extensively 
investigated.
Till now, most studies were confined to children, only a 
few studies have been done in adults[12,13] and no reports on 
adult HSP  patients presenting mainly with gastrointestinal 
symptoms are available. The aim of  this study was to 
evaluate the clinical significance of  ANCA in adult HSP 
patients who presented mainly with gastrointestinal 
symptoms and its role in the diagnosis of  HSP and its 
relationship to the disease severity.
MATERIALS AND METHODS
Patient selection
From February 2003 to March 2006, all adult HSP patients 
(age > 20 years) with prominent gastrointestinal symptoms, 
admitted to West China Hospital of  Sichuan University, 
were enrolled in the study. All the patients fulfilled the HSP 
diagnostic criteria[18]. During the same period, non-HSP 
inpatients with similar gastrointestinal symptoms served 
as the control group. Only patients without preexisting 
medical comorbidity were included in this study. Patients 
with known inflammatory bowel disease or autoimmune 
diseases were excluded from the study.
ANCA detection by indirect immunofluorescence (IIF)
The method is commercially established and provided 
by EUROIMMU Company (Germany). Briefly, serum 
samples were diluted at 1:3.2 in a phosphate- buffered 
solution (PBS), then 25 µL was applied to slides, and 
incubated at room temperature for 30 min. After the 
slides were washed with PBS, 20 µL FITC-labeled affinity-
purified goat anti-human IgG (EUROIMMU Company, 
Germany) was applied to the slides and incubated at room 
temperature for 30 min. Fluorescence microscopy was 
performed and the results were interpreted as negative 
for lack of  fluorescence and positive for the presence of  
moderate or intense fluorescence.
ANCA detection by ELISA for PR-3, MPO, EL, Cath-G, LF 
and BPI
The ELISA kit from EUROIMMU Company (Germany) 
was used. Briefly, 100 µL of  patient serum diluted at 1:100, 
positive and negative controls were put in 96-well plates 
(coated with PR-3, MPO, EL, Cath-G, LF or BPI) and 
incubated at room temperature for 30 min. After washed 
with PBS, 100 µL enzyme-labeled rabbit antihuman 
IgG (EUROIMMU Company, Germany) was added 
to the wells and incubated for 30 min. After washing, 
100 µL enzyme substrate (TMB/H2O2) was added to the 
wells, and incubated for 15 min. The reaction was then 
terminated by adding 100 µL sulfuric acid (0.5 mol/L). 
The absorbance was read at 450 nm with an automated 
plate reader. The result was expressed as (serum sample 
OD-OD of  negative control)/[(C-blank OD) × 0.2)]. 
A value < 0.1 was regarded as negative and ≥ 0.1 as 
positive.
Other biochemical examinations
Twenty four-hour urinary protein, urinalysis, kidney function 
and antinuclear antibody (ANA) test and rheumatoid factor 
(RF) were performed in the clinical laboratory of  the 
hospital.
HSP clinical score
To stratify patients according to the disease severity, the 
clinical scoring system of  was used as previously described 
Table 1[19].
Statistical analysis
Results were given as mean ± SD and percentage. For 
statistical analysis, Student t test (for age, clinical scores, 
blood creatine, 24 h urinary protein) and χ2 test (for sex 
and clinical symptom percentages) were used. P < 0.05 was 
considered statistically significant.
RESULTS
Twenty-eight patients with a final diagnosis of  HSP 
who presented mainly with gastrointestinal symptoms 
were included in the study. All HSP patients eventually 
developed typical purpura lesions. The average clinical 
score was 5.32 ± 0.92. Twenty-seven patients with peptic 
ulcer (n = 10), colon cancer (n = 1), acute gastroenteritis 
(n = 6), irritable bowel syndrome (n = 6), and colonic 
polyps (n = 4) served as controls. Age and sex distribution 
were comparable between the two groups (P > 0.05). The 
demographics, symptom percentages in both groups are 
listed in Table 2.
All the patients were negative for ANA. Only one 
HSP patient was found to have a positive RF test. Of  the 
23 patients who could recall the occurring time of  their 
symptoms, 5 complained of  GI symptoms preceding 
purpura while 18 complained of  purpura preceding the GI 
symptoms.
ANCA was detected in 9 HSP patients. Of  them, 2 had 
Table 1  Clinical scores for HSP
Symptom Score
Purpura
   below the umbilicus    1+
   above the umbilicus    2+
Abdominal pain
   Stool occult blood < 2+    1+
   Stool occult blood > 2+    2+
Joint pain    1+
Renal involvement
   Urinary occult blood 1+    1+
   Urinary occult blood 2+    2+
   Urinary occult blood 3+    3+
C-ANCA (Figure 1A) and 7 had P-ANCA (Figure 1B). 
No ANCA was detected in the controls (Table 3). The 
sensitivity and specificity of  positive ANCA were 32.1% 
and 100% respectively. ELISA was performed for the 9 
patients with positive ANCA detected by indirect IIF. Only 
one patient was positive for ANCA and the antigen was 
myeloperoxidase (MPO).
HSP patients who were positive for ANCA had higher 
clinical scores (6.79 ± 0.72 vs 4.12 ± 0.63, P = 0.02), and 
a higher rate for renal involvement as indicated by serum 
creatine level and 24 h urinary protein at the time of  
diagnosis (Table 4). Baseline kidney function tests were 
not available for most patients. However, given the lack of  
preexisting medical conditions, HSP was the most likely 
culprit for renal impairment in these patients.
HSP clinical scores and ANCA positive rates in patients 
with early and late purpura were also analyzed (Table 5). 
The latter was associated with a higher clinical score, but 
the GI symptoms and ANCA positive rate were similar in 
the two groups.
Typical case presentation
Case 1: A 28-year-old male was admitted for vomiting and 
diarrhea for 5 d and oliguria for 1 d. Physical examination 
on admission showed mild tenderness in the mid upper 
abdomen. Stool analysis showed white blood cells (+) and 
red blood cells (+). Renal function test showed moderately 
elevated blood BUN and creatine. Urinary analysis showed 
occult blood (++). “Acute gastroenteritis and acute renal 
function failure” were the initial diagnosis on admission. 
Infusion of  2 liters of  intravenous fluid did not result in any 
clinical improvement. Serum ANCA test was positive. Three 
days later, typical purpura appeared on his lower extremities 
and HSP was thus diagnosed. The symptoms disappeared 
after one-month intravenous cyclosporine therapy.
Case 2: A 26-year-old male was admitted for abdominal 
pain and hematochezia for 4 d, and hematuria for 1 d. 
Physical examination was normal. Blood examination 
showed moderate anemia. Urinalysis showed red blood 
cells (++). Renal ultrasound was normal. An upper 
endoscopy showed edema and congestion in the pyloric 
region (Figure 2A). Colonoscopy showed several petechiae 
scattering throughout the colon (Figure 2B). ANCA test 
was positive. Four days later, typical purpura appeared in 
his hips and lower extremities. All symptoms disappeared 
three weeks after treatment with prednisone.
Table 2  Comparison of demographic data between HSP 
patients and controls 
HSP Control P  value
n 28 27 NS1
Gender (male/female) 15/13 11/16 NS
Age (yr) (mean ± SD) 29.8 ± 8.1 30.1 ± 8.6 NS
   Age range (yr) 20-46 22-52
Symptoms
   Abdominal pain (%) 53.6 59.8 NS
   Hematochezia (%) 46.4 51.2 NS
   Diarrhea (%) 21.4 32.1 NS
   Vomiting (%) 10.7 14.8 NS
B
A
Figure 1  Strong cytoplasmic (A) and nuclear (B) staining patterns of ANCA 
(C-ANCA and P-ANCA) detected by indirect IIF. Serum samples from patients 
were diluted and incubated with primary antibody, then with FITC-labeled affinity-
purified goat anti-human IgG. The results were observed under fluorescence 
microscope. 
Table 3  ANCA detected by IIF in HSP patients and controls
1NS denotes no significance. 
+ANCA by IIF - ANCA by IIF
HSP 9 19
control 0 27
Table 4  Blood creatine and 24 h urinary protein in HSP 
patients (mean ± SD)
Blood creatine (µmol/L) 24 h urinary protein (g/L)
ANCA (+) 320 ± 22 (3.64 ± 0.25 mg/dL) 1.78 ± 0.12
ANCA (-)  104 ± 15b (1.19 ± 0.16 mg/dL)  0.78 ± 0.32c
bP = 0.01, cP = 0.03.
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DISCUSSION
HSP is an immune-complex mediated vasculitis, affecting 
small vessels in skin, gut and glomeruli[20] and is characterized 
by polymorphonuclear leukocytic infiltration of  the vessel 
wall. Mucosal lesions of  HSP can occur anywhere in 
the GI tract, and the small intestine is unfortunately the 
most commonly affected[21,22]. In 10%-15% HSP patients, 
gastrointestinal symptoms precede the cutaneous lesions[23]. 
The GI manifestation in these patients is usually severe and 
sometimes requires laparotomy. Our study also showed that 
the patients with GI symptoms preceding the purpura had 
higher clinical scores, but unfortunately their GI symptoms 
were nonspecific.
ANCA is an auto-antibody existing in peripheral blood, 
and has a high specificity for and sensitivity to certain 
vasculitis. Saulsbury tested ANCA in 29 HSP patients and 
none was positive[10], suggesting that ANCA is not a useful 
diagnostic tool for HSP. Renato and Robson et al[11,12] have 
also found a low prevalence of  ANCA in HSP, indicating that 
ANCA is not related to HSP. On the contrary, it was reported 
the prevalence (79%) of  ANCA is high in HSP patients[13,24]. 
Faith et al[14] also showed that IgA ANCA is 82.3% in children 
with HSP, demonstrating that ANCA is a useful test to 
confirm the diagnosis of  HSP in children. In our study, the 
specificity and sensitivity of  ANCA were 100% and 32.1%, 
respectively. Due to its high specificity, a positive test result 
can be very helpful in making the early diagnosis of  HSP 
before cutaneous lesions occur. However, our study excluded 
ulcerative colitis (UC) patients. According to recent studies, 
ANCA is recorded in 50%-70% of  patients with UC[25]. 
Because UC has its own characteristic clinical manifestations, 
especially specific colonoscopic manifestation, it is very easy 
for GI doctors to differentiate UC from HSP.
The reasons why the reported results are different may 
be as follows. (1) IIF is a crude test method its results may 
be affected by many factors such as RF and fibronectin, 
and interfered with the different process and conditions 
of  the study. In our study, RF was found only 1 patient, 
suggesting that it is not the reason why ANCA test was 
positive in our study. (2) Specific antigens are insufficient. 
The main target antigens of  ANCA lay in the azurophil 
granules of  neutrophils. Only five specific antigens have 
been identified so far for ANCA, including proteinase 3 
(PR-3), myeloperoxidase (MPO), leukocyte elastase (EL), 
cathepsin G (CG), lactoferrin (LF)[26]. In our study, we 
tested the binding of  the five antigens to ANCA by ELISA. 
The result showed that only one HSP serum sample had 
reactivity against anti-MPO, which is in agreement with 
previous reports, indicating that the five antigens are not 
specific antigens for ANCA. However, little is known about 
the specific antigens for ANCA. Ronda et al[13] analyzed the 
target antigen by Western blot using four strongest ANCA 
positive serum samples and found that a 51-kDa protein can 
be recognized in the neutrophil extract, indicating that the 
target antigens of  ANCA may be different in patients with 
HSP and vasculitis. Discovery of  more specific antigens for 
ANCA is needed to improve its value for clinical utilization. 
(3) It also may be related to the selection bias of  cases. 
Some studies showed that different expressions of  HLA are 
interfered with the expression of  ANCA. 
Our results show that a positive ANCA test was 
associated with a higher HSP score and a higher rate for renal 
dysfunction and urinary abnormality, which is consistent with 
the data reported by Shaw and Esnault[27,28], who found that 
patients with worse kidney function and higher urinary protein 
level have a higher ANCA titer, showing that ANCA is related 
to the activity of  HSP. These findings suggest that ANCA 
may take part in the pathogenesis of  HSP. The presence of  
ANCA in the sera of  patients may exert both stimulatory and 
inhibitory effects on neutrophil and monocyte functions. It 
can stimulate the oxidative burst and degranulation, leading 
to the release of  reactive oxygen intermediates. Enzymes 
from granules may directly damage the target tissues, 
inhibit the microbicidal activity of  polymorphonuclears, 
thus aggravating the neutrophil/macrophage dysfunction 
by inadequate elimination of  the infectious agents[29]. This 
may lead to the Th1/Th2 lymphocyte imbalance, leading to 
tissue damage and perpetuation of  chronic inflammation. In 
addition, ANCA may influence the process of  physiologic cell 
death. It was reported that ANCA can induce apoptosis of  
neutrophils, phagocytosis of  apoptotic neutrophils opsonized 
by ANCA induces oxidative metabolism of  monocytes, and 
defective apoptosis of  neutrophils may thus exacerbate the 
tissue damage[30].
In conclusion, after exclusion of  UC, a positive ANCA 
test in patients presenting mainly with GI symptoms can 
provide a clue to the diagnosis of  HSP. Patients with a 
positive ANCA develop more severe symptoms and are 
more likely to have their kidneys involved. HSP patients 
with positive ANCA initially presenting with only GI 
symptoms should receive a more aggressive therapy. Since 
our sample was small, further studies are needed to find 
the exact antigens for ANCA in HSP patients.
Figure 2  Gastroendoscopy showing edema and congestion in the pyloric region 
(A) and several petechiae scattering throughout the colon (B). 
A
B




Gastrointestinal symptoms are the common symptoms of Henoch-Schönlein purpura 
(HSP). Early diagnosis of HSP with gastrointestinal symptoms is difficult and some 
patients even undergo unnecessary laparotomy. Improving the early diagnosis of 
HSP still remains a challenge to both gastroenterologists and general surgeons.
Research frontiers
Antineutrophil cytoplasmic antibody (ANCA) is a useful tool for the diagnosis of 
systemic vasculitis. Recent studies indicate that ANCA is also detected in patients 
with HSP. However, its prevalence remains controversial. In addition, it was 
reported that ANCA is also related to the severity of many autoimmunological 
diseases, but the relationship between ANCA and the severity of HSP has not 
been extensively investigated.
Innovations and breakthrough
Most studies on HSP have been confined to children and no reports are available 
on adult HSP patients presenting mainly with gastrointestinal symptoms. In the 
present study, the authors found that ANCA positive test had a high specificity in 
HSP patients with gastrointestinal symptoms and HSP patients with ANCA positive 
had a higher clinical score.
Applications
ANCA may be a useful marker for the diagnosis of HSP with gastrointestinal symptoms.
Peer review
This paper investigated the significance of ANCA in HSP patients presenting with 
gastrointestinal symptoms. The authors concluded that a positive ANCA test could 
diagnose HSP in adult patients. HSP patients with positive ANCA have more 
serious symptoms.
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